Is Dianthus Therapeutics, Inc. overvalued?

Dianthus Therapeutics, Inc. (DNTH) — key valuation metrics and fundamentals.

No verdict

Price

$109.60

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$6.13B

Dividend yield

0.0%

Return on equity

-3.5%

Sector

Healthcare

Fair value compares DNTH's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks